BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32578456)

  • 1. Retinal vein occlusion and chronic kidney disease: A meta-analysis.
    Fang LJ; Dong L; Li YF; Wei WB
    Eur J Ophthalmol; 2021 Jul; 31(4):1945-1952. PubMed ID: 32578456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of glaucoma with risk of retinal vein occlusion: A meta-analysis.
    Yin X; Li J; Zhang B; Lu P
    Acta Ophthalmol; 2019 Nov; 97(7):652-659. PubMed ID: 31125174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End Stage Renal Disease as a Potential Risk Factor for Retinal Vein Occlusion.
    Chen SN; Yang TC; Lin JT; Lian IB
    Medicine (Baltimore); 2015 Nov; 94(47):e1960. PubMed ID: 26632690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and risk factors of retinal vein occlusion: the Gutenberg Health Study.
    Ponto KA; Elbaz H; Peto T; Laubert-Reh D; Binder H; Wild PS; Lackner K; Pfeiffer N; Mirshahi A
    J Thromb Haemost; 2015 Jul; 13(7):1254-63. PubMed ID: 25894549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global epidemiology of retinal vein occlusion: a systematic review and meta-analysis of prevalence, incidence, and risk factors.
    Song P; Xu Y; Zha M; Zhang Y; Rudan I
    J Glob Health; 2019 Jun; 9(1):010427. PubMed ID: 31131101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, pattern and risk factors of retinal vein occlusion in an elderly population in Nepal: the Bhaktapur retina study.
    Thapa R; Bajimaya S; Paudyal G; Khanal S; Tan S; Thapa SS; van Rens G
    BMC Ophthalmol; 2017 Sep; 17(1):162. PubMed ID: 28865424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prevalence of retinal vein occlusion: pooled data from population studies from the United States, Europe, Asia, and Australia.
    Rogers S; McIntosh RL; Cheung N; Lim L; Wang JJ; Mitchell P; Kowalski JW; Nguyen H; Wong TY;
    Ophthalmology; 2010 Feb; 117(2):313-9.e1. PubMed ID: 20022117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary angle closure and primary angle closure glaucoma in retinal vein occlusion.
    Xu K; Wu L; Ma Z; Liu Y; Qian F
    Acta Ophthalmol; 2019 May; 97(3):e364-e372. PubMed ID: 30239140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombophilic risk factors in different types of retinal vein occlusion in Tunisian patients.
    Mrad M; Fekih-Mrissa N; Wathek C; Rannen R; Gabsi S; Gritli N
    J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1592-8. PubMed ID: 24630828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes mellitus as a risk factor for retinal vein occlusion: A meta-analysis.
    Wang Y; Wu S; Wen F; Cao Q
    Medicine (Baltimore); 2020 Feb; 99(9):e19319. PubMed ID: 32118761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spectrum of Eye Disease in Diabetes (SPEED) in India: A prospective facility-based study. Report # 3. Retinal vascular occlusion in patients with type 2 diabetes mellitus.
    Bhattacharjee H; Barman M; Misra D; Multani PK; Dhar S; Behera UC; Das T; Gilbert C; Murthy GVS; Rajalakshmi R; Pant HB;
    Indian J Ophthalmol; 2020 Feb; 68(Suppl 1):S27-S31. PubMed ID: 31937725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of visual prognosis and correlative factors in retinal vein occlusion].
    Zhang H; Xia Y
    Zhonghua Yan Ke Za Zhi; 2002 Feb; 38(2):98-102. PubMed ID: 11955310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nine-year incidence and risk factors for retinal vein occlusion in a general Japanese population: the Hisayama Study.
    Arakawa S; Yasuda M; Nagata M; Ninomiya T; Hirakawa Y; Doi Y; Kiyohara Y; Ishibashi T
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5905-9. PubMed ID: 21693603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Retinal Vein Occlusion Following End-Stage Renal Disease.
    Chang YS; Weng SF; Chang C; Wang JJ; Tseng SH; Wang JY; Jan RL
    Medicine (Baltimore); 2016 Apr; 95(16):e3474. PubMed ID: 27100450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose-6-phosphate dehydrogenase deficiency in retinal vein occlusion.
    Pinna A; Carru C; Solinas G; Zinellu A; Carta F
    Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2747-52. PubMed ID: 17525208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Retinal Vein Occlusion in Patients With End-Stage Renal Disease: A 12-Year, Retrospective, Nationwide Cohort Study in South Korea.
    Lee KS; Nam KH; Kim DW; Kang EC; Koh HJ
    Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):39-44. PubMed ID: 29302692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Baseline characteristics and risk factors of retinal vein occlusion: a study by the Korean RVO Study Group.
    Lee JY; Yoon YH; Kim HK; Yoon HS; Kang SW; Kim JG; Park KH; Jo YJ;
    J Korean Med Sci; 2013 Jan; 28(1):136-44. PubMed ID: 23341724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between retinal vein occlusion and an increased risk of acute myocardial infarction: A nationwide population-based follow-up study.
    Chen YY; Sheu SJ; Hu HY; Chu D; Chou P
    PLoS One; 2017; 12(9):e0184016. PubMed ID: 28898259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematologic abnormalities associated with various types of retinal vein occlusion.
    Hayreh SS; Zimmerman MB; Podhajsky P
    Graefes Arch Clin Exp Ophthalmol; 2002 Mar; 240(3):180-96. PubMed ID: 11935275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cardiovascular risk factors on incidence and severity of Retinal Vein Occlusion.
    Pacella F; Bongiovanni G; Malvasi M; Trovato Battagliola E; Pistone A; Scalinci SZ; Basili S; La Torre G; Pacella E
    Clin Ter; 2020; 171(6):e534-e538. PubMed ID: 33151253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.